Floatz logo

ATORVASTATIN

Cerebrovascular Disorder

Sichuan Provincial People's HospitalSmall moleculePhase 4 / ApprovedActive
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
95/ 100

Competitive context

12 Active assets in the Cerebrovascular Disorder cohort.

Asset / SponsorPhaseRating
WARFARIN
Seoul National University Hospital
Phase 4BBB
Aspirin
Peking Union Medical College Hospital
Phase 3BB
Cilostazol
Zhejiang Provincial People's Hospital
Phase 3BB
Tirofiban
Peking Union Medical College Hospital
Phase 3BB
Tenecteplase
University of Melbourne
Phase 3BB

View all 34 →

Same molecule, other indications

ATORVASTATIN is also rated in:

inherited lipid metabolism disorderActive
A
Indicative · Phase 4
83 / 100
View asset →
hyperlipidemiaDormant
BBB
Indicative · Phase 4
79 / 100
View asset →
cardiovascular disorderActive
BBB
Indicative · Phase 4
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →